Australia markets closed

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
170.81+10.94 (+6.84%)
At close: 4:00PM EDT

168.84 -1.97 (-1.15%)
Pre-market: 8:01AM EDT

Full screen
Trade prices are not sourced from all markets
Previous close159.87
Open158.68
Bid169.20 x 800
Ask169.66 x 1200
Day's range158.21 - 171.92
52-week range43.11 - 189.26
Volume19,044,899
Avg. volume10,999,267
Market cap68.414B
Beta (5Y monthly)1.38
PE ratio (TTM)N/A
EPS (TTM)-1.96
Earnings date06 May 2021
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est175.58
  • The Moderna CEO's Bold Statement That May Mean Bad News for Novavax
    Motley Fool

    The Moderna CEO's Bold Statement That May Mean Bad News for Novavax

    Moderna (NASDAQ: MRNA) beat Novavax (NASDAQ: NVAX) to market with a coronavirus vaccine. The U.S. Food and Drug Administration (FDA) authorized Moderna's candidate in December. Novavax expects to report U.S. phase 3 trial data in the coming weeks and complete an Emergency Use Authorization (EUA) request this quarter.

  • Financial Times

    Italy seeks domestic production of mRNA Covid vaccines

    Italy has held talks with several manufacturers about starting production of mRNA-based Covid-19 vaccines in the country, in the latest sign that European officials want to deepen those supplies over other types of shot. Rome has discussed the domestic production of mRNA-based vaccines with US biotech Moderna, Switzerland’s Novartis and Italy’s ReiThera, people familiar with the matter said. The recent talks with Novartis and ReiThera included the possibility of producing the mRNA vaccine developed by Germany’s CureVac in Italy, two of the people said.

  • Moderna cuts UK COVID vaccine deliveries as pregnant women told mRNA jabs are safe
    Yahoo Finance UK

    Moderna cuts UK COVID vaccine deliveries as pregnant women told mRNA jabs are safe

    The Moderna jab, which works in a similar way to the Pfizer vaccine, uses synthetic messenger RNA (mRNA) technology that can be quickly tweaked to address new mutations of a virus.